Biogen enters ophthalmology gene therapy field with Nightstar takeover Roche becomes a major gene therapy player with the acquisition of Spark Therapeutics Targetgin Nr4a transcription factors a possible strategies for combatting CAR-T cell exhaustion in solid tumour treatment Second patient HIV free after stem cell transplant: renewed interest in gene therapies targeting CCR5? Gilead and MaxCyte expand CAR-T partnership Orchard presents encouraging follow up data of trial of stem cell gene therapy for ADA-SCID Autolus partners with software company Veneti to make production and delivery of CAR-T cell therapies more efficient BioPharm partners with Trinity College Dublin to develop cell-based cancer treatments
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!